Edition:
United Kingdom

People: Beigene Ltd (BGNE.OQ)

BGNE.OQ on NASDAQ Stock Exchange Global Select Market

113.99USD
17 Jun 2019
Change (% chg)

$-3.63 (-3.09%)
Prev Close
$117.62
Open
$119.22
Day's High
$119.39
Day's Low
$113.24
Volume
193,089
Avg. Vol
101,552
52-wk High
$194.56
52-wk Low
$105.19

Oyler, John 

Mr. John Victor Oyler is Executive Chairman of the Board, Chief Executive Officer of the Company. He has served as a member of our Board since October 2010. From 2005 to 2009, Mr. Oyler served as President and Chief Executive Officer of BioDuro, LLC, a drug discovery outsourcing company, which was acquired by Pharmaceutical Product Development Inc. From 2002 to 2004, Mr. Oyler served as Chief Executive Officer of Galenea Corp., a biopharmaceutical company dedicated to the discovery of novel therapies for central nervous system diseases, which initially were developed at Massachusetts Institute of Technology. From 1998 to 2002, Mr. Oyler was a Founder and the President of Telephia, Inc. which was bought by The Nielsen Company in 2007. From 1997 to 1998, Mr. Oyler served as Co-Chief Executive Officer of Genta Incorporated, an oncology-focused biopharmaceutical company listed on the Nasdaq under ticker symbol “GNTA”. Mr. Oyler began his career as a management consultant at McKinsey & Company. Mr. Oyler received his B.S. from the Massachusetts Institute of Technology in June, 1990 and an MBA from Stanford University in January, 1996.

Basic Compensation

Total Annual Compensation, USD 1,369,740
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 13,751
Fiscal Year Total, USD 1,383,490

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --